Sapiens International (SPNS)
(Real Time Quote from BATS)
$39.78 USD
-1.24 (-3.02%)
Updated Jul 24, 2024 12:20 PM ET
3-Hold of 5 3
D Value A Growth A Momentum B VGM
Price, Consensus and EPS Surprise
SPNS 39.78 -1.24(-3.02%)
Will SPNS be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for SPNS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for SPNS
Sapiens' (SPNS) Strong Portfolio, Clientele Make It a Buy Now
Sapiens (SPNS) Benefits From a Strong Portfolio, Partner Base
SPNS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Sapiens (SPNS) Upgraded to Strong Buy: Here's Why
Sapiens' (SPNS) Latest AI-Powered Platform Strengthens Portfolio
Sapiens (SPNS) Expands International Footprint With BKI Deal
Other News for SPNS
SAPIENS TO ANNOUNCE SECOND QUARTER OF 2024 FINANCIAL RESULTS ON AUGUST 1, 2024
Pan-American Life Insurance Group Goes Live with Sapiens IllustrationPro SaaS Solution for Rollout on Microsoft Azure Cloud
Sapiens to Unveil Q2 2024 Financial Results
Sapiens Modernizes PALIG’s Illustration System
S&P Global Ratings Maalot Confirms Ratings of Sapiens and its Series B Debentures as "ilAA-" with a Stable Outlook/ "ilAA-"